Clincorp Medical Lab Inc is categorized under Business Consultants in Long Island City, NY and active since 2009.
Clincorp Medical Lab Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Jaswinder Dhillon at the company’s single location by writing to 3427 Steinway St # 102, Long Island City, New York NY 11101 or by phoning (718) 880-5493. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clincorp Medical Lab Inc |
| Contact Person: | Jaswinder Dhillon |
| Address: | 3427 Steinway St # 102, Long Island City, New York 11101 |
| Phone Number: | (718) 880-5493 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Clincorp Medical Lab Inc was started in 2009 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jaswinder Dhillon for inquiries that concern Clincorp Medical Lab Inc by calling the company number (718) 880-5493, as your correspondence is most welcome. Additionally, the physical location of the single location of Clincorp Medical Lab Inc can be found at the coordinates 40.755193,-73.921863 as well as the street address 3427 Steinway St # 102 in Long Island City, New York 11101.
For its online presence, you may visit Clincorp Medical Lab Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.